MindBar founder Hailey O’Neill wanted to make sure keeping up with mental health isn't a luxury. Photo courtesy of MindBar

Much easier than finding a therapist is finding laments at the cost and accessibility of mental health care. Group therapy is more affordable, but still a pricey and intimidating commitment. Text therapy like BetterHelp costs a lot more and often feels stilted. Now, a new Texas-based platform is paving the way for another option.

Although it may not replace the need for talk therapy entirely, MindBar, which launched in Austin in July, spreads the workload of coaches and therapists across many clients, keeps things online, and ultimately sets users up at their own pace. Like MasterClass for mental health, the app reduces the barrier to entry to just $14.99 per month.

The one-way service definitely can’t listen and identify a user’s thought patterns, or recommend personalized courses of action, but it can provide a wide series of useful primers to bring into talk therapy later, augment less frequent sessions, or just facilitate some preventative care and curiosity about the mind.

“MindBar has gained considerable traction since its launch in July, and our members have enjoyed the wide range of tools to cultivate a healthy mind,” writes MindBar founder Hailey O’Neill in an email interview. “We set out to represent the idea that mental health is a right, not a luxury, and the growth we’ve already seen within our app and its members is beginning to deliver on that ambition.”

Although MindBar is not therapy, it's also not YouTube. Classes take an experience or topic — stress, grief, and self-esteem to name a few — and break it down into video modules and worksheets. Each is organized and taught by one “teacher,” whose qualifications are clearly laid out in her biography from “years of coaching,” to therapy certifications and PhDs. Instead of browsing individual videos, users join each class; it’s just a click, but it feels distinct from mental health apps that encourage tackling everything at once.

Take the “Body Image” class as an example: It contains six modules of around 15 minutes, each paired with a multi-part “worksheet" of open-ended questions and text boxes for journaling on the platform. These are then wrapped up in a friendly little print out for those who’d prefer to write. If a user decided to moderate their own experience to simulate the commitment of traditional therapy (say 50 minutes biweekly), just taking this class could fill six to twelve weeks. Compare $30 for two months of MindBar to $450 for three therapy sessions.

Since MindBar exposes a user to the theory and methods of one particular professional, further avenues open up for extra or post-curricular work. Molly Seifert teaches “Body Image.” On Seifert’s MindBar biography page, there’s a link to her website and social media. Her credentials point out her 22-episode podcast, What She Gained, adding roughly 10 hours of free content to a user’s journey, should they follow her off the platform.

There is a button to book a session — something MindBar is working on finalizing — and on Seifert’s website, she offers a more involved “Body Confidence Program” that costs $897. Most users likely will not end up signing up for a teacher’s nearly-$1,000 group therapy track. However, the opportunity is there to follow this thread from a dip of the toes to a full-blown client-provider relationship.

A 2021 report by Sapien Labs’ Mental Health Million Project 2021 found that in the United States, 37 percent of respondents who did not seek help for clinical mental health problems did so because they lacked confidence in the mental health system. Nearly as many, 34 percent, did not know what kind of help to seek. More than a quarter preferred self-help. Imagine the shift if these respondents had a self-paced, minimal commitment platform that funneled them to professionals they learned to trust.

As of August 31, 2022, there are 26 classes on MindBar. Sign up at mind-bar.com.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.